Booser DJ - Search Results

1

Anthracycline antibiotics in cancer therapy. Focus on drug resistance.

Booser DJ, Hortobagyi GN. Booser DJ, et al. Drugs. 1994 Feb;47(2):223-58. doi: 10.2165/00003495-199447020-00002. Drugs. 1994. PMID: 7512899 Review.

2

Treatment of locally advanced breast cancer.

Booser DJ, Hortobagyi GN. Booser DJ, et al. Semin Oncol. 1992 Jun;19(3):278-85. Semin Oncol. 1992. PMID: 1609294 Review.

3

Phase II study of deoxyspergualin in metastatic breast cancer.

Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, Holmes F, Buzdar A, Fraschini G, Hortobagyi G. Dhingra K, et al. Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965. Invest New Drugs. 1994. PMID: 7896543 Clinical Trial.

4

The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer.

Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Fraschini G, Buzdar AU, Frye D, Gibbs HR, Hortobagyi GN. Holmes FA, et al. Among authors: booser dj. J Natl Cancer Inst Monogr. 1993;(15):161-9. J Natl Cancer Inst Monogr. 1993. PMID: 7912522 Clinical Trial.

5

Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.

Buzdar AU, Hortobagyi GN, Frye D, Ho D, Booser DJ, Valero V, Holmes FA, Birmingham BK, Bui K, Yeh C, et al. Buzdar AU, et al. Among authors: booser dj. J Clin Oncol. 1994 Jan;12(1):50-4. doi: 10.1200/JCO.1994.12.1.50. J Clin Oncol. 1994. PMID: 8270984 Clinical Trial.

6

Phase I trial of droloxifene in patients with metastatic breast cancer.

Buzdar AU, Kau S, Hortobagyi GN, Theriault RL, Booser D, Holmes FA, Walters R, Krakoff IH. Buzdar AU, et al. Cancer Chemother Pharmacol. 1994;33(4):313-6. doi: 10.1007/BF00685906. Cancer Chemother Pharmacol. 1994. PMID: 8281625 Clinical Trial.

7

Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.

Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Hortobagyi GN. Buzdar AU, et al. Among authors: booser dj. Surg Oncol Clin N Am. 1995 Oct;4(4):715-34. Surg Oncol Clin N Am. 1995. PMID: 8535907

8

Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer.

Walters RS, Theriault RL, Booser DJ, Esparza L, Hortobagyi GN. Walters RS, et al. Among authors: booser dj. J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):185-7. doi: 10.1097/00002371-199510000-00006. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8770774 Clinical Trial.

9

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.

Holmes FA, Madden T, Newman RA, Valero V, Theriault RL, Fraschini G, Walters RS, Booser DJ, Buzdar AU, Willey J, Hortobagyi GN. Holmes FA, et al. Among authors: booser dj. J Clin Oncol. 1996 Oct;14(10):2713-21. doi: 10.1200/JCO.1996.14.10.2713. J Clin Oncol. 1996. PMID: 8874332 Clinical Trial.

10

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.

Valero V, Jones SE, Von Hoff DD, Booser DJ, Mennel RG, Ravdin PM, Holmes FA, Rahman Z, Schottstaedt MW, Erban JK, Esparza-Guerra L, Earhart RH, Hortobagyi GN, Burris HA 3rd. Valero V, et al. Among authors: booser dj. J Clin Oncol. 1998 Oct;16(10):3362-8. doi: 10.1200/JCO.1998.16.10.3362. J Clin Oncol. 1998. PMID: 9779713 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters